Facebook
Twitter
LinkedIn

Newsletter

Don’t Miss National Cancer Institute Funding Opportunities
Facebook
Twitter
LinkedIn

The Small Business Innovation Research & Small Business Technology Transfer (SBIR & STTR) Programs represent one of the largest sources of early-stage technology financing in the United States. Funding is available to support small businesses working across a wide range of cancer-related research topic areas through the SBIR & STTR Omnibus Solicitation, an investigator-initiated grant funding opportunity. The next deadline to submit applications is August 5, 2013.

All applicants to the National Cancer Institute (NCI) SBIR & STTR programs must use the re-issued PHS 2013-2 Omnibus Grant Solicitations, PA-13-234 (SBIR) and PA-13-235 (STTR) for the upcoming August 5 and December 5 deadlines. The NCI SBIR & STTR Programs have additional targeted grant funding opportunities available in various topic areas to help small businesses advance their research concepts towards commercialization.

Apply today.

In an email to BayBio, the program administrator shared important information about the reissued omnibus solicitation. The original SBIR and STTR Omnibus solicitations, PA-13-088 (SBIR) and PA-13-089 (STTR) are now EXPIRED.

  • Applicants will receive an error during submission if these expired funding opportunity announcements (FOAs) are used.
  • Please download and use the ACTIVE re-issued Omnibus Solicitation FOAs (PA-13-234, SBIR and PA-13-235, STTR) for all applications to the remaining due dates. This includes resubmissions (‘-A1s’).

The re-issued 2013 Omnibus Solicitation expands eligibility and impacts the application process, so please read the solicitations carefully. With this re-issue, the NIH SBIR/STTR programs implement the following provisions of the SBIR/STTR Reauthorization Act:

  • Small business concerns that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms are now eligible to apply to the NIH SBIR program and compete for up to 25% of NIH’s SBIR set-aside.
  • All applicants are required to register at the SBA Company Registry prior to application submission and attach proof of registration. See below for the full list of registration requirements for submitting SBIR/STTR applications to HHS.

For further details, please see NIH Guide Notice NOT-OD-13-071 or check the NIH implementation plan website.

To view the official re-issued 2013 SBIR & STTR Omnibus Solicitations, please visit:

SBIR Program
PA-13-234, Re-issue PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Receipt Dates: August 5, 2013; December 5, 2013

STTR Program
PA-13-235
, Re-issue PHS 2013-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
Receipt Dates: August 5, 2013; December 5, 2013

Sign up to receive updates about SBIR & STTR funding opportunities at sbir.cancer.gov.